- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03805321
The Validity of Peripheral Perfusion Index to Predict Fluid Responsiveness
The Validity of Peripheral Perfusion Index to Predict Fluid Responsiveness Using Mini-fluid Challenge Test
Study Overview
Status
Conditions
Detailed Description
The concept of fluid responsiveness has been suggested to guide fluid administration in critically ill patients to avoid either over or under-transfusion.
Several methods have been suggested to detect fluid responsiveness. Mini fluid challenge with concomitant monitoring of stroke volume is one of the most robust methods for pre-load challenge.
The main foreshortening of mini fluid challenge method is the need for a real-time cardiac output monitor, to track the instantaneous change of stroke vole with changing body position. Finding a surrogate to cardiac output to trace the effect of mini fluid challenge would make the test more applicable without the need for advanced hemodynamic monitors.
There is a growing interest in the use of perfusion indices in assessment of fluid responsiveness. Perfusion indices are measures for adequacy of oxygen delivery in peripheral tissues; thus, they were hypothesized to be possible surrogates of cardiac output. Peripheral perfusion index represents "the ratio between the pulsatile and non-pulsatile component of the light reaching the pulse oximeter" . Peripheral perfusion index has been considered as a numerical non-invasive measure for peripheral perfusion. PPI has the advantage over other perfusion indices that it a non-invasive, user-friendly monitor.
The aim of this work is to investigate the ability of peripheral perfusion index to predict the hemodynamic response to mini-fluid challenge in patients with septic shock.
Mini-fluid challenge test will be performed by infusion of 200 mL Lactated Ringer's solution over 1 minute. Velocity time integral will be monitored using Transthoracic echocardiography at the left ventricular outflow tract at the apical five-chamber view. Cardiac output will be calculated, and the patient will be considered fluid-responder if cardiac output increased by 10% after fluid challenge.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 11432
- Ahmed Mohamed Hasanin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Septic shock patients
Exclusion Criteria:
- Evident blood loss
- Peripheral vascular disorders
- Upper limb injury or burns
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peripheral perfusion index
Time Frame: 2 hours
|
It is a number describing the ratio between pulsatile and non-pulsatile blood flow measured by pulse oximeter.
It is measured in percent.
with the best value of 20% and the worst value of 0.1%
|
2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Velocity time integral
Time Frame: 2 hours
|
it is a parameter measured from Doppler across the left ventricular outflow tract.
It is calculated by dividing the blood velocity by time and measured in cm
|
2 hours
|
|
Mean arterial blood pressure
Time Frame: 2 hours
|
Mean arterial blood pressure measured in mmHg
|
2 hours
|
|
Central venous pressure
Time Frame: 2 hours
|
Central venous pressure measured from a central venous catheter.
It is measured in cmH2o
|
2 hours
|
|
Systolic arterial blood pressure
Time Frame: 2 hours
|
Systolic arterial blood pressure measured in mmHg
|
2 hours
|
|
Diastolic arterial blood pressure
Time Frame: 2 hours
|
Diastolic arterial blood pressure measured in mmHg
|
2 hours
|
|
Cardiac output
Time Frame: 2 hours
|
The amount of blood pumped by the heart in one minute.
it is measured as liters per minute
|
2 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Ahmed Shash, Professor, Head of department of anesthesia, Cairo University, Egypt
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- N-138-2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Septic Shock
-
German Center for Neurodegenerative Diseases (DZNE)University Hospital, BonnUnknownSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockGermany
-
Laiba QamarRecruitingSeptic Shock | Fluid Refractory Septic ShockPakistan
-
University Medicine GreifswaldUnknownSepsis Septic ShockGermany
-
Artcline GmbHRecruitingSepsis | Septic Shock | Immunoparalysis in Septic ShockGermany
-
Assistance Publique - Hôpitaux de ParisCompletedSeptic Shock HyperdynamicFrance
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
Centre Hospitalier Universitaire DijonCompleted
-
Mansoura UniversityCompleted
-
University of ZurichCompletedPatients in Septic ShockSwitzerland
-
Rennes University HospitalTerminated